Alyssum Pharma Private Limited
About Alyssum Pharma Private Limited
Data last updated:
Alyssum Pharma Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 12 August 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2014PTC033029. Its GSTIN is 23AACCF4580B1Z4 (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Force Pharma Private Limited. It is led by directors including Nandan Rai Jaidka and Pankaj Shrivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No. 1 Main Road Barkhedi, Bhopal, Madhya Pradesh, India – 462001.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.99 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net loss of ₹42,570 (net margin -1.3%) and EBITDA of -₹42,280 (EBITDA margin -1.3%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 3% over five years.
As per MCA filings, the company has satisfied charges of ₹5 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Alyssum Pharma Private Limited's registered office is in Bhopal, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressHouse No. 1 Main Road Barkhedi, Bhopal, Madhya Pradesh, India – 462001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Alyssum Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Alyssum Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alyssum Pharma Private Limited, buy the company report.
Financials of Alyssum Pharma Private Limited
FY 2025 filings availableAlyssum Pharma Private Limited reported revenue of ₹31.99 Lakh (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 1% fall in the latest year. EBITDA rose 94% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹42,280 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹42,570 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1.3% | ||||
| Net Profit Margin | -1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alyssum Pharma Private Limited, buy the company report.
Board of directors of Alyssum Pharma Private Limited
Alyssum Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandan Rai Jaidka | Director | 23 May 2016 | 10 Years 5 Months | Current |
| Pankaj Shrivastava | Director | 23 May 2016 | 10 Years 5 Months | Current |
| Mukesh Soni | Director | 23 May 2016 | 10 Years 5 Months | Current |
| Anil Khatri Also directs: Adinil Pharma Private Limited | Director | 23 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Alyssum Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shankhpani Healthcare Private Limited | ₹32.13 Lakh (FY 2024) | -11.0% | Varanasi, Uttar Pradesh, India | |||
| Mebo Pharmaceutical (India) Private Limited | ₹32.07 Lakh (FY 2025) | -9.0% | New Delhi, Delhi, India | |||
| Alyssum Pharma Private Limitedthis company | ₹31.99 Lakh (FY 2024) | -₹42,570 | -1.3% | -1.0% | Bhopal, Madhya Pradesh, India | |
| Mega Biosciences Private Limited | ₹31.95 Lakh (FY 2024) | -24.0% | New Delhi, Delhi, India | |||
| Taparia Tex Fab Private Limited | ₹31.94 Lakh (FY 2025) | 12.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Alyssum Pharma Private Limited, buy the company report.
Auditor
Alyssum Pharma Private Limited is audited by SUBODH KUMAR JOSHI & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUBODH KUMAR JOSHI & CO. | FY 2017 | 079280 |
Shareholding
The shareholding of Alyssum Pharma Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Alyssum Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Feb 2020 | 100376873 | Bank of India | ₹5 Lakh | Satisfied |
To see the full charge records of Alyssum Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Alyssum Pharma Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Civil suit | Filed against the company by Pharma Force Lab & Anr | Disposed |
To see the full case history of Alyssum Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alyssum Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alyssum Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCF4580B1Z4 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Alyssum Pharma Private Limited, buy the company report.
Recent activity
Alyssum Pharma Private Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Ajit Singh Kushwah ceased to be Director on 24 May 2016.
Frequently asked questions
Alyssum Pharma is an active private limited company based in Bhopal, Madhya Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 12 August 2014 (12+ years old) and is registered under CIN U24232MP2014PTC033029.
Alyssum Pharma has 4 current directors:
- Nandan Rai Jaidka - Director
- Pankaj Shrivastava - Director
- Mukesh Soni - Director
- Anil Khatri - Director
The latest financial statements of Alyssum Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Alyssum Pharma is 23AACCF4580B1Z4, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Alyssum Pharma is U24232MP2014PTC033029. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alyssum Pharma has 2 court cases on record: 2 filed against it.
Alyssum Pharma was incorporated on 12 August 2014, making it 12+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Alyssum Pharma by revenue are Shankhpani Healthcare Private Limited, Mebo Pharmaceutical (India) Private Limited, Mega Biosciences Private Limited, Taparia Tex Fab Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ajit Singh Kushwah ceased to be Director on 24 May 2016. Dileep Namdev ceased to be Director on 24 May 2016. Anil Khatri was appointed as Director on 23 May 2016. Alyssum Pharma has 6 board changes on record in total.
The registered office of Alyssum Pharma is at House No. 1 Main Road Barkhedi, Bhopal, Madhya Pradesh, India – 462001.
Alyssum Pharma operates in the trading industry, in the other wholesale segment.